“QSAR Study and Molecular Docking of 23‐Hydroxybetulinic Acid Derivatives as RMGPa and HeLa Cells Inhibitors”, Commun. Comput. Chem., vol. 3, no. 3, pp. 75–102, Mar. 2015, doi: 10.4208/cicc.2015.v3.n3.2.